US and UK Partner to Speed Up Approval of Medical Devices
US and UK Partner to Speed Up Approval of Medical Devices
In a move that signals a new era of regulatory diplomacy, the UK and US have partnered to accelerate the approval of cutting-edge medical devices.
By aligning the work of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the U.S.
Food and Drug Administration (FDA), the two nations aim to reduce redundant hurdles and foster global innovation.
A key component is the development of reliance routes, allowing the MHRA to leverage established US pathways like the 510(k), De Novo, and Premarket Approval (PMA) processes.
Furthermore, the MHRA is engaging with US experts to shape standards for AI in healthcare.
By bridging the gap between domestic needs and global benchmarks, the UK is positioning itself as an innovation-ready hub, proving that smart regulatory policy can directly benefit patient health on both sides of the Atlantic.
